- Home
- BKE vs IMCR Comparison
BKE vs IMCR Comparison
Compare BKE & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BKE | IMCR |
|---|---|---|
| Founded | 1948 | 2008 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.8B |
| IPO Year | 1996 | 2016 |
Fundamental Metrics
Financial Performance| Metric | BKE | IMCR |
|---|---|---|
| Price | $44.23 | $36.77 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 10 |
| Target Price | $53.00 | ★ $66.33 |
| AVG Volume (30 Days) | 387.1K | ★ 406.6K |
| Earning Date | 05-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 7.96% | N/A |
| EPS Growth | 6.43 | ★ 30.39 |
| EPS | ★ 0.92 | 0.23 |
| Revenue | ★ $1,297,835,000.00 | $249,428,000.00 |
| Revenue This Year | $5.10 | $14.57 |
| Revenue Next Year | $4.99 | $8.21 |
| P/E Ratio | ★ $48.27 | $159.17 |
| Revenue Growth | 6.58 | ★ 43.05 |
| 52 Week Low | $40.73 | $27.56 |
| 52 Week High | $61.69 | $40.71 |
Technical Indicators
Market Signals| Indicator | BKE | IMCR |
|---|---|---|
| Relative Strength Index (RSI) | 49.47 | 65.62 |
| Support Level | $41.15 | $35.46 |
| Resistance Level | $46.09 | $37.25 |
| Average True Range (ATR) | 1.12 | 1.32 |
| MACD | -0.20 | 0.20 |
| Stochastic Oscillator | 44.30 | 87.30 |
Price Performance
Historical ComparisonAbout BKE Buckle Inc. (The)
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to affordable priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.